患有ERBB2插入突变的晚期盆癌患者:一个病例报告

Peipei Shang1, Cheng Lou1, Lei Yin1

  • 1Department of Oncology, Shanghai Eastern Hepatobiliary Surgery Hospital, Anting Town, Jiading District, Shanghai, China.

概括

患有ERBB2突变的晚期盆癌症初步对trastuzumab产生反应. 然而,药物耐药性发展,突出了治疗这种罕见癌症的挑战.